FDA Priority Review Voucher Redemption Fee Set At $4.6 Million In FY 2011
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Redeeming a priority review voucher obtained by developing a drug for a tropical disease will cost companies $6.1 million in fiscal 2011